2016
DOI: 10.1088/1752-7155/10/1/016011
|View full text |Cite
|
Sign up to set email alerts
|

Metabolomics analysis of exhaled breath condensate for discrimination between lung cancer patients and risk factor individuals

Abstract: The search for new clinical tests aimed at diagnosing chronic respiratory diseases is a current research line motivated by the lack of efficient screening tools and the severity of some of these pathologies. Alternative biological samples can open the door to new screening tools. A promising biofluid that is rarely used for diagnostic purposes is exhaled breath condensate (EBC), the composition of which has been inadequately studied. In this research, untargeted analysis of EBC using gas chromatography time-of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
18
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(18 citation statements)
references
References 44 publications
0
18
0
Order By: Relevance
“…Squalene is also present in exhaled breath condensate and, at this level, can be used to discriminate between a cohort of patients with lung cancer, risk factor subjects (active smokers and ex‐smokers), and healthy individuals …”
Section: Squalene In Other Locationsmentioning
confidence: 99%
“…Squalene is also present in exhaled breath condensate and, at this level, can be used to discriminate between a cohort of patients with lung cancer, risk factor subjects (active smokers and ex‐smokers), and healthy individuals …”
Section: Squalene In Other Locationsmentioning
confidence: 99%
“…Just in the case of cancer has metabolomics been applied to study lung, kidney, prostate, gastric, colorectal, ovarian [5], liver, brain [6], and breast cancer tissues [7]. Among other types of mammalian samples metabolomics studies on cerebrospinal [8] or amniotic [9] fluids, exhaled breath condensate [10], stool, or saliva [11] samples were performed.…”
Section: Introductionmentioning
confidence: 99%
“…However, in almost all cases, the prediction in terms of analysis sensitivity and specificity of these tests have been limited [ 125 ]. Recent research conducted by Peralbo-Molina et al [ 126 ] involved the analysis of breath samples from smoking, non-smoking and past smoking patients in order to detect the metabolic signature within exhaled breath condensate for risk and cancer affected individuals. In addition to the previously detected alkanes [ 125 ], a high resolution GC-TOF-MS approach was able to identify monoglycerols and squalene as the prominent signature metabolites.…”
Section: Breathomics and Salivaomics Applicationsmentioning
confidence: 99%